Literature DB >> 32779875

Osteosarcoma.

Bree R Eaton1, Rudolf Schwarz2, Ralph Vatner3, Brian Yeh4, Line Claude5, Daniel J Indelicato6, Nadia Laack7.   

Abstract

Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This paper reviews the general management and standard radiotherapy guidelines for osteosarcoma in both North America and Europe in a joined effort between the Children's Oncology Group and International Society of Pediatric Oncology. Standard treatment involves multiagent induction chemotherapy followed by surgical resection for local tumor control and consolidation local control to metastatic sites. Radiotherapy is reserved for cases with a marginal or incomplete resection or for definitive treatment in the case of unresectable disease. We present supporting data for the role of chemotherapy, surgery, and radiation therapy.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  chemotherapy; metastasis; osteosarcoma; radiotherapy; surgery

Year:  2020        PMID: 32779875     DOI: 10.1002/pbc.28352

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  24 in total

Review 1.  LncRNA MALAT1-related signaling pathways in osteosarcoma.

Authors:  Maryam Farzaneh; Sajad Najafi; Omid Anbiyaee; Shirin Azizidoost; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-07-06       Impact factor: 3.340

2.  Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Tomohiko Ito; Naohiro Oka; Ryosuke Kakinoki; Masao Akagi
Journal:  Eur J Histochem       Date:  2022-06-23       Impact factor: 1.966

Review 3.  Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.

Authors:  Dave N T Aryee; Valerie Fock; Utkarsh Kapoor; Branka Radic-Sarikas; Heinrich Kovar
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

Review 4.  Osteosarcoma: a review of current and future therapeutic approaches.

Authors:  Xin Zhao; Qirui Wu; Xiuqing Gong; Jinfeng Liu; Yujie Ma
Journal:  Biomed Eng Online       Date:  2021-03-02       Impact factor: 2.819

5.  Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.

Authors:  Renna Qiu; Denghua Sun; Yuzhuo Bai; Jiannan Li; Lizhe Wang
Journal:  Drug Deliv       Date:  2020-11-28       Impact factor: 6.419

6.  The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma.

Authors:  Guangxian Zhong; Yunqing Wang; Hongxiang Wei; Meifang Chen; Huangfeng Lin; Zhen Huang; Jinlong Huang; Shenglin Wang; Jianhua Lin
Journal:  Int J Gen Med       Date:  2021-10-07

7.  CircFAM120B knockdown inhibits osteosarcoma tumorigenesis via the miR-1205/PTBP1 axis.

Authors:  Jia-Ju Li; Ming-Yue Xiong; Tian-Yu Sun; Chang-Bin Ji; Run-Tao Guo; Ya-Wei Li; Hong-Yu Guo
Journal:  Aging (Albany NY)       Date:  2021-10-29       Impact factor: 5.682

8.  ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.

Authors:  Zhaojie Qin; Kai Luo; Wenyu Feng; Xinli Zhan; Yun Liu; Shijie Liao; Juliang He; Mingwei He; Tianyu Xie; Xiaohong Jiang; Boxiang Li; Huijiang Liu; Qian Huang; Haijun Tang
Journal:  Int J Gen Med       Date:  2022-02-02

9.  Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS.

Authors:  Dongming Lv; Yutong Zou; Ziliang Zeng; Hao Yao; Shirong Ding; Yiying Bian; Lili Wen; Xianbiao Xie
Journal:  Metabolomics       Date:  2020-11-18       Impact factor: 4.290

10.  Double Endoprosthesis in the Management of Refractory Metastatic Primary Bone Tumors in Children and Young Adults.

Authors:  Anna Raciborska; Iwona Malesza; Katarzyna Bilska; Tomasz Koziński; Bartosz Pachuta
Journal:  Adv Orthop       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.